Ionis reports second quarter 2021 financial results and recent business achievements
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Nasdaq, S&P end lower as tech stocks fall
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Rescue work underway after quakes rock Venezuela, 'high casualties' likely
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
Ionis Pharmaceuticals (IONS) Tops Q2 EPS by 1c
August 4, 2021 7:12 AM EDTIonis Pharmaceuticals (NASDAQ: IONS) reported Q2 EPS of ($0.57), $0.01 better than the analyst estimate of ($0.58). Revenue for the quarter came in at $126 million versus the consensus estimate of $129.94 million.
GUIDANCE:
Ionis Pharmaceuticals sees FY2021 revenue of $600 million, versus the consensus of $618... More
